Viewing Study NCT06764095

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:17 PM
Ignite Modification Date: 2026-02-03 @ 1:31 AM
Study NCT ID: NCT06764095
Status: RECRUITING
Last Update Posted: 2025-09-15
First Post: 2024-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Bladder Urothelial Carcinoma View
None Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma View
None Metastatic Bladder Urothelial Carcinoma View
None Metastatic Renal Pelvis and Ureter Urothelial Carcinoma View
None Stage III Bladder Cancer AJCC v8 View
None Stage IV Bladder Cancer AJCC v8 View
None Stage IV Renal Pelvis and Ureter Cancer AJCC v8 View
Keywords: